The effects of equine peripheral blood stem cells on cutaneous wound healing: a clinical evaluation in four horses

Summary Stem‐cell therapy represents a promising strategy for the treatment of challenging pathologies, such as large, infected wounds that are unresponsive to conventional therapies. The present study describes the clinical application of peripheral blood stem cells (PBSCs) for the treatment of fou...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental dermatology Vol. 38; no. 3; pp. 280 - 284
Main Authors: Spaas, J. H., Broeckx, S., Van de Walle, G. R., Polettini, M.
Format: Journal Article
Language:English
Published: England Blackwell Publishing Ltd 01-04-2013
Oxford University Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Stem‐cell therapy represents a promising strategy for the treatment of challenging pathologies, such as large, infected wounds that are unresponsive to conventional therapies. The present study describes the clinical application of peripheral blood stem cells (PBSCs) for the treatment of four adult Warmblood horses with naturally occurring wounds, which were unresponsive to conventional therapies for at least 3 months. A visual assessment was performed, and a number of wound‐healing parameters (granulation tissue, crust formation and scar formation) were evaluated. In all cases, tissue overgrowth was visible within 4 weeks after PBSC injection, followed by the formation of crusts and small scars in the centre of the wound, with hair regeneration at the edges. In conclusion, this is the first report of PBSC therapy of skin wounds in horses, and it produced a positive visual and clinical outcome.
Bibliography:ark:/67375/WNG-L9G0320W-P
ArticleID:CED12068
istex:59A17A6337430081ADB90EBE4DED153F45C3971C
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
Conflict of interest: MP declares competing financial interests under patent number: 07 820134.0-12222 and as a member of Thankstem s.r.l. The other authors have no competing interests to declare.
ISSN:0307-6938
1365-2230
DOI:10.1111/ced.12068